Siriwardena A Niroshan, Qureshi M Zubair, Dyas Jane V, Middleton Hugh, Orner Roderick
Faculty of Health, Life and Social Sciences, University of Lincoln, Brayford Pool, Lincoln.
Br J Gen Pract. 2008 Jun;58(551):417-22. doi: 10.3399/bjgp08X299290.
Little is known about patients' perceptions of newer hypnotics.
To investigate use, experience, and perceptions of Z drug and benzodiazepine hypnotics in the community.
Cross-sectional survey of general practice patients who had received at least one prescription for a Z drug or benzodiazepine in the previous 6 months.
Lincolnshire, UK.
Self-administered postal questionnaire.
Of 1600 surveys posted, 935 (58.4%) responses were received, of which 705 (75.4%) were from patients taking drugs for insomnia. Of those 705 patients, 87.9% (n = 620) were first prescribed a hypnotic by their GP, and 94.9% (n = 669) had taken a sleeping tablet for 4 weeks or more. At least one side effect was reported in 41.8% (n = 295); 18.6% wished to come off hypnotic medication; and 48.5% had tried to stop treatment. Patients on Z drugs were more likely to express a wish to stop (22.7% versus 12.3%; odds ratio [OR] = 1.67, 95% confidence interval [CI] = 1.13 to 2.49), or to have attempted to come off medication, than those on benzodiazepines (52.4% versus 41.0%; OR = 1.54, 95% CI = 1.12 to 2.12). The two groups did not differ significantly in respect of benefits or adverse effects.
There were no significant differences in patients' perceptions of efficacy or side-effects reported by those on Z drugs compared to patients taking benzodiazepines. Side-effects were commonly reported, which may have contributed to a high proportion of responders, particularly patients on Z drugs who were wishing to stop, or who had previously tried to stop taking this medication. Reported prescribing practices were often at variance with the licence for short-term use.
关于患者对新型催眠药的看法知之甚少。
调查社区中Z类药物和苯二氮䓬类催眠药的使用情况、用药体验及患者看法。
对在过去6个月内至少接受过一次Z类药物或苯二氮䓬类药物处方的全科医疗患者进行横断面调查。
英国林肯郡。
自行填写的邮寄问卷。
在寄出的1600份调查问卷中,共收到935份回复(58.4%),其中705份(75.4%)来自服用失眠药物的患者。在这705名患者中,87.9%(n = 620)最初是由其全科医生开具催眠药处方的,94.9%(n = 669)服用安眠药达4周或更长时间。41.8%(n = 295)的患者报告至少出现一种副作用;18.6%的患者希望停用催眠药物;48.5%的患者曾试图停止治疗。与服用苯二氮䓬类药物的患者相比,服用Z类药物的患者更有可能表示希望停药(22.7%对12.3%;优势比[OR]=1.67,95%置信区间[CI]=1.13至2.49),或曾试图停药(52.4%对41.0%;OR = 1.54,95%CI = 1.12至2.12)。两组在获益或不良反应方面无显著差异。
与服用苯二氮䓬类药物的患者相比,服用Z类药物的患者在疗效或副作用看法上无显著差异。副作用报告普遍,这可能是导致较高回复率的原因,尤其是那些希望停药或曾试图停药的服用Z类药物的患者。报告的处方做法往往与短期使用许可不一致。